In the same manner, since the role of PD-1 has been reported in various TI immune cells and tumor cells, an entire examination of PD-1 expression in TIME can predict which cell are dominantly targeted by PD-1 therapy and the therapeutic effect of PD-1 therapy induced by certain cells. This evidence concerns the gene PDCD1 and neoplasm.